# Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC

> **NCT02709720** · PHASE2 · COMPLETED · sponsor: **Spanish Lung Cancer Group** · enrollment: 68 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Vinorelbine
- **DRUG:** Cisplatin
- **DRUG:** Vinorelbine
- **DRUG:** Cisplatin
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT02709720
- **Lead sponsor:** Spanish Lung Cancer Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-15
- **Primary completion:** 2019-04-15
- **Final completion:** 2019-12-16
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02709720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02709720, "Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02709720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*